Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zaks

Showing results (331-340 of 370) with videos related to

Pageof 37
Sort By:
Nature Medicine|April 22, 2022
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virusAllison August, Husain Z Attarwala, Sunny Himansu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2024
Office or home versus 24-h blood pressure measurement in stable kidney transplant recipientsGeorgios Eleftheriadis, Marcel G Naik, Bilgin Osmanodja, et al.
Experimental Eye Research|January 6, 2021
In-vivo imaging for assessing tumor growth in mouse models of ocular melanomaOrtal Zaks, Dimitri Gaber, Keren Ben-Yaakov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancerHelen J Ross, George R Blumenschein, Joseph Aisner, et al.
Journal of Autoimmunity|November 15, 2012
Progranulin antibodies in autoimmune diseasesLorenz Thurner, Klaus-Dieter Preuss, Natalie Fadle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2022
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza VirusesKapil Bahl, Joe J Senn, Olga Yuzhakov, et al.
Journal of Autoimmunity|May 26, 2015
The molecular basis for development of proinflammatory autoantibodies to progranulinLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Vaccine|May 14, 2019
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trialsRobert A Feldman, Rainard Fuhr, Igor Smolenov, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2017
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza VirusesKapil Bahl, Joe J Senn, Olga Yuzhakov, et al.
Chemmedchem|March 17, 2015
A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS)Tamar Getter, Ilana Zaks, Yael Barhum, et al.
Pageof 37

Showing results (331-340 of 370) with videos related to

Sort By:
Pageof 37
Nature Medicine|April 22, 2022
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virusAllison August, Husain Z Attarwala, Sunny Himansu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2024
Office or home versus 24-h blood pressure measurement in stable kidney transplant recipientsGeorgios Eleftheriadis, Marcel G Naik, Bilgin Osmanodja, et al.
Experimental Eye Research|January 6, 2021
In-vivo imaging for assessing tumor growth in mouse models of ocular melanomaOrtal Zaks, Dimitri Gaber, Keren Ben-Yaakov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancerHelen J Ross, George R Blumenschein, Joseph Aisner, et al.
Journal of Autoimmunity|November 15, 2012
Progranulin antibodies in autoimmune diseasesLorenz Thurner, Klaus-Dieter Preuss, Natalie Fadle, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 3, 2022
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza VirusesKapil Bahl, Joe J Senn, Olga Yuzhakov, et al.
Journal of Autoimmunity|May 26, 2015
The molecular basis for development of proinflammatory autoantibodies to progranulinLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Vaccine|May 14, 2019
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trialsRobert A Feldman, Rainard Fuhr, Igor Smolenov, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 2, 2017
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza VirusesKapil Bahl, Joe J Senn, Olga Yuzhakov, et al.
Chemmedchem|March 17, 2015
A chemical chaperone-based drug candidate is effective in a mouse model of amyotrophic lateral sclerosis (ALS)Tamar Getter, Ilana Zaks, Yael Barhum, et al.
Pageof 37